Correction to : Efficacy of Bacillus Calmette-Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial
Errataetall: |
ErratumFor: Infect Dis Ther. 2022 Dec;11(6):2205-2217. - PMID 36242739 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Infectious diseases and therapy - 12(2023), 3 vom: 16. März, Seite 1017-1018 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sinha, Sanjeev [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 16.03.2023 published: Print ErratumFor: Infect Dis Ther. 2022 Dec;11(6):2205-2217. - PMID 36242739 Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1007/s40121-023-00770-9 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM35301818X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM35301818X | ||
003 | DE-627 | ||
005 | 20231226055034.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s40121-023-00770-9 |2 doi | |
028 | 5 | 2 | |a pubmed24n1176.xml |
035 | |a (DE-627)NLM35301818X | ||
035 | |a (NLM)36795304 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sinha, Sanjeev |e verfasserin |4 aut | |
245 | 1 | 0 | |a Correction to |b Efficacy of Bacillus Calmette-Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 16.03.2023 | ||
500 | |a published: Print | ||
500 | |a ErratumFor: Infect Dis Ther. 2022 Dec;11(6):2205-2217. - PMID 36242739 | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
650 | 4 | |a Published Erratum | |
700 | 1 | |a Ajayababu, Anuj |e verfasserin |4 aut | |
700 | 1 | |a Thukral, Himanshu |e verfasserin |4 aut | |
700 | 1 | |a Gupta, Sushil |e verfasserin |4 aut | |
700 | 1 | |a Guha, Subhasish Kamal |e verfasserin |4 aut | |
700 | 1 | |a Basu, Ayan |e verfasserin |4 aut | |
700 | 1 | |a Gupta, Gaurav |e verfasserin |4 aut | |
700 | 1 | |a Thakur, Prashant |e verfasserin |4 aut | |
700 | 1 | |a Lingaiah, Raghavendra |e verfasserin |4 aut | |
700 | 1 | |a Das, Bimal Kumar |e verfasserin |4 aut | |
700 | 1 | |a Singh, Urvashi B |e verfasserin |4 aut | |
700 | 1 | |a Singh, Ravinder |e verfasserin |4 aut | |
700 | 1 | |a Narang, Rajiv |e verfasserin |4 aut | |
700 | 1 | |a Bhowmik, Dipankar |e verfasserin |4 aut | |
700 | 1 | |a Wig, Naveet |e verfasserin |4 aut | |
700 | 1 | |a Modak, Dolan Champa |e verfasserin |4 aut | |
700 | 1 | |a Bandyopadhyay, Bhaswati |e verfasserin |4 aut | |
700 | 1 | |a Chakrabarty, Banya |e verfasserin |4 aut | |
700 | 1 | |a Kapoor, Aditya |e verfasserin |4 aut | |
700 | 1 | |a Tewari, Satyendra |e verfasserin |4 aut | |
700 | 1 | |a Prasad, Narayan |e verfasserin |4 aut | |
700 | 1 | |a Hashim, Zia |e verfasserin |4 aut | |
700 | 1 | |a Nath, Alok |e verfasserin |4 aut | |
700 | 1 | |a Kumari, Niraj |e verfasserin |4 aut | |
700 | 1 | |a Goswami, Ravinder |e verfasserin |4 aut | |
700 | 1 | |a Pandey, Shivam |e verfasserin |4 aut | |
700 | 1 | |a Pandey, Ravindra Mohan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Infectious diseases and therapy |d 2012 |g 12(2023), 3 vom: 16. März, Seite 1017-1018 |w (DE-627)NLM240483693 |x 2193-8229 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2023 |g number:3 |g day:16 |g month:03 |g pages:1017-1018 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s40121-023-00770-9 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2023 |e 3 |b 16 |c 03 |h 1017-1018 |